Allogene Therapeutics, Inc. short interest in 2022
In 2022, Allogene Therapeutics, Inc.'s disclosed short interest ran from 6.37% of shares outstanding on 14 Jan 2022 to 23.18% on 30 Dec 2022, a change of +16.81 percentage points. The year's high was 23.18% on 30 Dec 2022 and its low 6.37% on 14 Jan 2022, averaging 14.96% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 23.85 days on 31 Oct 2022. Full history: Allogene Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 6.37% (14 Jan 2022)
- End of year
- 23.18% (30 Dec 2022)
- Change
- +16.81 pp
- High
- 23.18% (30 Dec 2022)
- Low
- 6.37% (14 Jan 2022)
- Average
- 14.96%
- Highest days to cover
- 23.85 (31 Oct 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 6.37% | 4.52 | |
| 31 Jan 2022 | 6.69% | 4.97 | |
| 15 Feb 2022 | 7.36% | 9.53 | |
| 28 Feb 2022 | 8.59% | 6.71 | 10-K filed, results (8-K) |
| 15 Mar 2022 | 10.20% | 9.68 | |
| 31 Mar 2022 | 10.69% | 7.82 | |
| 14 Apr 2022 | 12.68% | 13.42 | |
| 29 Apr 2022 | 12.46% | 8.84 | |
| 13 May 2022 | 12.32% | 7.19 | 10-Q filed, results (8-K) |
| 31 May 2022 | 14.03% | 12.81 | |
| 15 Jun 2022 | 15.36% | 10.35 | |
| 30 Jun 2022 | 15.66% | 6.93 | |
| 15 Jul 2022 | 15.62% | 11.33 | |
| 29 Jul 2022 | 15.60% | 18.68 | |
| 15 Aug 2022 | 15.69% | 12.08 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 15.31% | 19.44 | |
| 15 Sep 2022 | 15.45% | 15.06 | |
| 30 Sep 2022 | 19.18% | 10.87 | |
| 14 Oct 2022 | 20.90% | 16.94 | |
| 31 Oct 2022 | 21.47% | 23.85 | |
| 15 Nov 2022 | 21.81% | 17.08 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 21.13% | 14.52 | |
| 15 Dec 2022 | 21.17% | 17.49 | |
| 30 Dec 2022 | 23.18% | 15.59 |
See also: Allogene Therapeutics, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.